Contrast-enhanced mammography for newly diagnosed breast cancer in women with breast augmentation: Preliminary findings

Molly B. Carnahan; Barbara Pockaj; Victor Pizzitola; Marina E. Giurescu; Roxanne Lorans; William Eversman; Richard E. Sharpe; Patricia Cronin; Bhavika K. Patel

doi:10.2214/AJR.20.25341

Contrast-enhanced mammography for newly diagnosed breast cancer in women with breast augmentation: Preliminary findings

Molly B. Carnahan, Barbara Pockaj, Victor Pizzitola, Marina E. Giurescu, Roxanne Lorans, William Eversman, Richard E. Sharpe, Patricia Cronin, Bhavika K. Patel

Research output: Contribution to journal › Article › peer-review

Abstract

In 17 women with newly diagnosed breast cancer who underwent contrast-enhanced mammography (CEM) and MRI, both modalities were found to be concordant for the index cancer. In six of the 17 women, CEM showed an additional lesion that was confirmed by MRI. Of these six additional lesions, three were multifocal, one was multicentric, and two were contralateral; two of the six were malignant. MRI did not identify any additional cancers that were not identified on CEM. CEM may have a role in women with breast augmentation and either a contraindication or limited access to MRI.

Original language	English (US)
Pages (from-to)	855-856
Number of pages	2
Journal	American Journal of Roentgenology
Volume	217
Issue number	4
DOIs	https://doi.org/10.2214/AJR.20.25341
State	Published - Oct 2021

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.2214/AJR.20.25341

Cite this

@article{f38fb9ad162543e98be6c3be656fca18,

title = "Contrast-enhanced mammography for newly diagnosed breast cancer in women with breast augmentation: Preliminary findings",

abstract = "In 17 women with newly diagnosed breast cancer who underwent contrast-enhanced mammography (CEM) and MRI, both modalities were found to be concordant for the index cancer. In six of the 17 women, CEM showed an additional lesion that was confirmed by MRI. Of these six additional lesions, three were multifocal, one was multicentric, and two were contralateral; two of the six were malignant. MRI did not identify any additional cancers that were not identified on CEM. CEM may have a role in women with breast augmentation and either a contraindication or limited access to MRI.",

author = "Carnahan, {Molly B.} and Barbara Pockaj and Victor Pizzitola and Giurescu, {Marina E.} and Roxanne Lorans and William Eversman and Sharpe, {Richard E.} and Patricia Cronin and Patel, {Bhavika K.}",

year = "2021",

month = oct,

doi = "10.2214/AJR.20.25341",

language = "English (US)",

volume = "217",

pages = "855--856",

journal = "American Journal of Roentgenology",

issn = "0361-803X",

publisher = "American Roentgen Ray Society",

number = "4",

}

TY - JOUR

T1 - Contrast-enhanced mammography for newly diagnosed breast cancer in women with breast augmentation

T2 - Preliminary findings

AU - Carnahan, Molly B.

AU - Pockaj, Barbara

AU - Pizzitola, Victor

AU - Giurescu, Marina E.

AU - Lorans, Roxanne

AU - Eversman, William

AU - Sharpe, Richard E.

AU - Cronin, Patricia

AU - Patel, Bhavika K.

PY - 2021/10

Y1 - 2021/10

N2 - In 17 women with newly diagnosed breast cancer who underwent contrast-enhanced mammography (CEM) and MRI, both modalities were found to be concordant for the index cancer. In six of the 17 women, CEM showed an additional lesion that was confirmed by MRI. Of these six additional lesions, three were multifocal, one was multicentric, and two were contralateral; two of the six were malignant. MRI did not identify any additional cancers that were not identified on CEM. CEM may have a role in women with breast augmentation and either a contraindication or limited access to MRI.

AB - In 17 women with newly diagnosed breast cancer who underwent contrast-enhanced mammography (CEM) and MRI, both modalities were found to be concordant for the index cancer. In six of the 17 women, CEM showed an additional lesion that was confirmed by MRI. Of these six additional lesions, three were multifocal, one was multicentric, and two were contralateral; two of the six were malignant. MRI did not identify any additional cancers that were not identified on CEM. CEM may have a role in women with breast augmentation and either a contraindication or limited access to MRI.

UR - http://www.scopus.com/inward/record.url?scp=85115623530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85115623530&partnerID=8YFLogxK

U2 - 10.2214/AJR.20.25341

DO - 10.2214/AJR.20.25341

M3 - Article

C2 - 33728971

AN - SCOPUS:85115623530

SN - 0361-803X

VL - 217

SP - 855

EP - 856

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

IS - 4

ER -

Contrast-enhanced mammography for newly diagnosed breast cancer in women with breast augmentation: Preliminary findings

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this